PINK:PZRXQ

Phaserx Stock Forecast

etoro logo Buy PZRXQ
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Nov 17, 2025

PZRXQ Performance

FAQ

What is the symbol for PhaseRx, Inc. Stock and on which exchange is it traded?
The symbol for PhaseRx, Inc. is PZRXQ and it is traded on the PINK (Pink Sheets).

Should I buy or sell PhaseRx, Inc. Stock?
PhaseRx, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy PhaseRx, Inc. Stock?
PhaseRx, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy PhaseRx, Inc. Stock.

What's the current price of PhaseRx, Inc. Stock?
As of the end of day on the Nov 17, 2025, the price of an PhaseRx, Inc. (PZRXQ) share was $0.0001.

What is the 52-week high and low for PhaseRx, Inc. Stock?
The 52-week high for PhaseRx, Inc. Stock is $0.0002 and the 52-week low is $0.0001.

What is the market capitalization of PhaseRx, Inc. Stock?
As of the Nov 17, 2025, the market capitalization of PhaseRx, Inc. is 1.169K.
Click to get the best stock tips daily for free!
ABOUT PHASERX, INC.
PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The company develops its products based on its proprietary Hybrid mRNA technology platform, which allows the synthesis of missing enzyme inside the cell. Its therapeutic urea cycle disorder programs under development include PRX-OTC to treat ornith...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE